2016 International Congress Archives - Page 23 of 207

12:30pm-2:00pm: Implementation of a mobile application in the Luxembourg Parkinson’s study for identification and validation of disease stage and variation

R. Krüger, G. Hipp, M. Kerschenmeyer, P.L. Kolber, A. Trister, C. Suver, V.P. Satagopam, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Balling, S. Friend (Belvaux, Luxembourg)

Technology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Impulse control disorder associates with tyrosine hydroxylase 2 gene variants in Parkinson’s disease patients subject to dopaminergic therapy

I. Legarda, B. Vives, C.A. Beltran-Gomila, B. Ortega-Vila, M. Ruiz, J. Pol-Fuster, C. Vives-Bauza (Palma, Spain)

Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: In idiopathic Parkinson’s disease: The effect of using L-dopa on peripheral nerves

M.E. Temir, F. Genç, Y. Biçer Gömceli, A. Yaman, A. Aybar, E. Karaçay (Antalya, Turkey)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: In utero delivery of scAAV9 mediates widespread brain transduction in rats and monkeys: Towards new models of Parkinson’s disease

M. Bourdenx, L. Chansel-Debordeaux, S. Dovero, V. Grouyhier, N. Dutheil, S. Brun, A. Espagna, L. Groc, Q. Li, C. Jimenez, E. Bezard, B. Dehay (Bordeaux, France)

Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Incidence of waning tremor control in essential tremor patients with deep brain stimulation

M.D. Seier, A. Hiller, C. Murchison (Portland, OR, USA)

Tremor · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Incidental finding of drug-induced movement disorder

G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)

Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Increase L-dopa dosage for rest tremor or think about the essential tremor too?

A. Voskanyan, G. Avagyan, E. Khachatryan, K. Harutyunyan, S. Khachaturyan, H. Amirjanyan, H. Manvelyan (Yerevan, Armenia)

Tremor · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Increased anti-MAG autoantibodies titers in Parkinson’s disease

E. Papuc, K. Rejdak (Lublin, Poland)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Increased cellular co-localization of tau fragment 1-368 and alpha-synuclein in two mouse model of Parkinson’s disease

K. Ma, S. Nie, G. Chen, C. Han, X. Guo, Y. Xu, X. Cao (Wuhan, People's Republic of China)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Increased cerebrospinal fluid lactate levels in Parkison’s disease: Is it a proof of mitochondrial inefficiency?

C. Liguori, A. Stefani, E. Olivola, N.B. Mercuri, M. Pierantozzi (Rome, Italy)

Pathophysiology